Healthcare

Discover news, funding updates, regulatory changes, and sector insights impacting the health care industry in India.

Piramal Appoints Murari Rajan To Head M&A, Strategy

Healthcare

25 September, 2008

Piramal Appoints Murari Rajan To Head M&A, Strategy

Murari Rajan has joined Piramal Enterprises Ltd as Executive Director, where he will be responsible for Mergers & Acquisitions and Corporate ......

Healthcare

19 September, 2008

Medical Equipment Firm Opto Circuits To Acquire European Co For $100M

Healthcare equipment maker Opto Circuits has acquired an unnamed European company for over $100 million. This would be Opto's biggest ......

Healthcare

02 September, 2008

Biotech Firm Avesthagen Appoints Managers For IPO

Private equity backed biotech company Avestha Gengraine Technologies Pvt Ltd (Avesthagen) has appointed DSP Merrill Lynch as its lead manager ......

Healthcare

28 August, 2008

Columbia Pacific Raises $135 Million For Asian Hospital Arm

US-based investment fund Columbia Pacific has announced the closure of a $135 million second round of financing for its Asian ......

Healthcare

25 August, 2008

Everest Capital, CVCI Invest $24 Million In Nectar Lifesciences

Citi Venture Capital International (CVCI) and Everest Capital (M) Ltd have invested $23.6 million in pharmaceutical major Nectar Lifesciences. While ......

Healthcare

25 August, 2008

IFCI Venture Capital Invests $4.6M In Marck Biosciences

IFCI Venture Capital (IVCL)  has invested $4.6 million (Rs 20 crore) in Ahemadabad-based Marck Biosciences Ltd. The company is involved ......

Healthcare

19 August, 2008

Citi Venture, ICICI Venture Take Hair Cut In Perlecan Pharma

Hyderabad-based Dr. Reddy’s Laboratories’ is set to buy back the shares of Perlecan Pharma, its demerged arm dedicated to new ......

Healthcare

19 August, 2008

Bupa Asia-Pacific Picks Up 26% In Health Insurance JV With Max

Britain’s Bupa will pick up a 26 per cent stake - the maximum equity allowed to foreign investors in Indian ......

Healthcare

19 August, 2008

Ranbaxy Says US Investigations Have No Impact On $4.6-Billion Deal

Ranbaxy Pharmaceuticals has said that the ongoing investigations by US authorities on alleged forgery and concealment of data will not ......

Most Popular

Google News Icon

Google News

Follow VCCircle on Google News for the latest updates on Business and Startup News